109 related articles for article (PubMed ID: 8265999)
1. Disposal of atrial natriuretic factor (ANF99-126) in patients with cirrhosis: effect of beta-adrenergic blockade.
Bendtsen F; Gerbes AL; Henriksen JH
Scand J Clin Lab Invest; 1993 Oct; 53(6):547-54. PubMed ID: 8265999
[TBL] [Abstract][Full Text] [Related]
2. Hepatic-intestinal disposal of endogenous human alpha atrial natriuretic factor99-126 in patients with cirrhosis.
Henriksen JH; Bendtsen F; Schütten HJ; Warberg J
Am J Gastroenterol; 1990 Sep; 85(9):1155-9. PubMed ID: 2143885
[TBL] [Abstract][Full Text] [Related]
3. Increased circulating leptin in alcoholic cirrhosis: relation to release and disposal.
Henriksen JH; Holst JJ; Møller S; Brinch K; Bendtsen F
Hepatology; 1999 Jun; 29(6):1818-24. PubMed ID: 10347125
[TBL] [Abstract][Full Text] [Related]
4. Estimated central blood volume in cirrhosis: relationship to sympathetic nervous activity, beta-adrenergic blockade and atrial natriuretic factor.
Henriksen JH; Bendtsen F; Gerbes AL; Christensen NJ; Ring-Larsen H; Sørensen TI
Hepatology; 1992 Nov; 16(5):1163-70. PubMed ID: 1358779
[TBL] [Abstract][Full Text] [Related]
5. Effect of oral propranolol administration on azygos, renal and hepatic uptake and output of catecholamines in cirrhosis.
Bendtsen F; Christensen NJ; Sørensen TI; Henriksen JH
Hepatology; 1991 Aug; 14(2):237-43. PubMed ID: 1860681
[TBL] [Abstract][Full Text] [Related]
6. Splanchnic removal of human alpha-atrial natriuretic peptide in humans: enhancement after food intake.
Henriksen JH; Bendtsen F; Gerbes AL
Metabolism; 1990 May; 39(5):553-6. PubMed ID: 2139918
[TBL] [Abstract][Full Text] [Related]
7. Effects of alpha-adrenergic stimulation and beta-adrenergic blockade on azygos blood flow and splanchnic haemodynamics in patients with cirrhosis.
Mastai R; Bosch J; Navasa M; Kravetz D; Bruix J; Viola C; Rodés J
J Hepatol; 1987 Feb; 4(1):71-9. PubMed ID: 3033061
[TBL] [Abstract][Full Text] [Related]
8. [Atrial natriuretic factor in liver cirrhosis. Relation to hemodynamic parameters].
Tesar V; Horký K; Jedlicka J; Petrtýl J; Kopecká J; Gregorová I; Marecek Z; Perlík F; Kordac V
Cas Lek Cesk; 1990 Jan; 129(4):117-22. PubMed ID: 2139592
[TBL] [Abstract][Full Text] [Related]
9. Azygos and hepatic extraction of atrial natriuretic factor (ANF) in patients with cirrhosis. No evidence of reduced disposal.
Henriksen JH; Bendtsen F; Gerbes AL
J Hepatol; 1993 Mar; 17(3):419-20. PubMed ID: 8315270
[No Abstract] [Full Text] [Related]
10. Regional differences of atrial natriuretic factors in humans.
Os I; Thaulow E; Westheim A
Clin Physiol; 1993 Mar; 13(2):153-60. PubMed ID: 8453869
[TBL] [Abstract][Full Text] [Related]
11. Effect of oral propranolol on splanchnic oxygen uptake and haemodynamics in patients with cirrhosis.
Bendtsen F; Henriksen JH; Becker U; Sørensen TI
J Hepatol; 1987 Oct; 5(2):137-43. PubMed ID: 3693857
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic and plasma atrial natriuretic factor responses to cardiac volume loading in young versus older normotensive humans.
Legault L; van Nguyen P; Holliwell DL; Leenen FH
Can J Physiol Pharmacol; 1992 Dec; 70(12):1549-54. PubMed ID: 1301232
[TBL] [Abstract][Full Text] [Related]
13. Atrial natriuretic factor: comparability of venous and arterial plasma measurements in man at rest and during exercise.
Kanstrup IL; Høilund-Carlsen PF; Damkjaer Nielsen M; Marving J; Gadsbøll N
Clin Sci (Lond); 1989 Sep; 77(3):319-22. PubMed ID: 2530020
[TBL] [Abstract][Full Text] [Related]
14. Identification and plasma concentrations of the N-terminal fragment of proatrial natriuretic factor in man.
Sundsfjord JA; Thibault G; Larochelle P; Cantin M
J Clin Endocrinol Metab; 1988 Mar; 66(3):605-10. PubMed ID: 2965160
[TBL] [Abstract][Full Text] [Related]
15. Clearance of atrial natriuretic factor by lung, liver, and kidney in human subjects and the dog.
Hollister AS; Rodeheffer RJ; White FJ; Potts JR; Imada T; Inagami T
J Clin Invest; 1989 Feb; 83(2):623-8. PubMed ID: 2521490
[TBL] [Abstract][Full Text] [Related]
16. Brain natriuretic factor: regional plasma concentrations and correlations with haemodynamic state in cardiac disease.
Richards AM; Crozier IG; Yandle TG; Espiner EA; Ikram H; Nicholls MG
Br Heart J; 1993 May; 69(5):414-7. PubMed ID: 8390847
[TBL] [Abstract][Full Text] [Related]
17. Superior portosystemic collateral circulation estimated by azygos blood flow in patients with cirrhosis. Lack of correlation with oesophageal varices and gastrointestinal bleeding. Effect of propranolol.
Calès P; Braillon A; Jirón MI; Lebrec D
J Hepatol; 1985; 1(1):37-46. PubMed ID: 3877112
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of atrial peptides ANF (1-98) and ANF (99-126) as diagnostic markers of atrial distension in patients with cardiac disease.
Mathisen P; Hall C; Simonsen S
Scand J Clin Lab Invest; 1993 Feb; 53(1):41-9. PubMed ID: 8451600
[TBL] [Abstract][Full Text] [Related]
19. Human atrial natriuretic factor and renin-aldosterone in paracetamol induced fulminant hepatic failure.
Panos MZ; Anderson JV; Forbes A; Payne N; Slater JD; Rees L; Williams R
Gut; 1991 Jan; 32(1):85-9. PubMed ID: 1825077
[TBL] [Abstract][Full Text] [Related]
20. Muscle sympathetic nerve activity and renal responsiveness to atrial natriuretic factor during the development of hepatic ascites.
Morali GA; Floras JS; Legault L; Tobe S; Skorecki KL; Blendis LM
Am J Med; 1991 Oct; 91(4):383-92. PubMed ID: 1835288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
